MedTrace Logo

Feasibility of Immunotherapy Plus Chemotherapy Administration to Patients With Bronchial Cancer in a Hospital-at- Home Setting

NCT04802902 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2024-02-26

No results posted yet for this study

Summary

This observational prospective monosite study aims to describe, for the first time, management in a hospital-at-home programme of patients treated by immunotherapy-chemotherapy combo for bronchial cancer in maintenance phase of first row metastatic treatment.

The feasibility in good conditions of this management, the patients' quality of life and their satisfaction will be evaluated. A cost-benefit analysis will be done to compare hospital-at-home programme and classical day hospitalization.

Conditions

  • Bronchial Cancer

Interventions

OTHER

home-based hospitalization

management in a hospital-at-home programme of patients treated by immunotherapy and chimiotherapy combo for bronchial cancer

Sponsors & Collaborators

  • Centre Hospitalier de PAU

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-29
Primary Completion
2024-02-08
Completion
2024-02-08

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04802902 on ClinicalTrials.gov